
Fosaprineon 150mg Injection
Marketer
Neon Laboratories Ltd
Salt Composition
Fosaprepitant (150mg)
Overview Fosaprineon 150mg Injection
Chemotherapy-induced nausea and vomiting are prevented by the prescription medication Fosaprineon 150mg Injection. Administered by a healthcare professional, this injection should be taken consistently as scheduled. Discontinuing treatment prematurely requires prior consultation with your physician. If a dose is missed, take it immediately upon recollection, completing the prescribed course regardless of symptom improvement. Regular liver function tests may be recommended by your doctor during treatment. Potential side effects include fatigue, headache, appetite loss, constipation, and hiccups. Dizziness and drowsiness are also possible; avoid driving or activities demanding concentration until the medication's effects are understood.
Primary Ingredients of Fosaprineon 150mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Fosaprineon 150mg Injection
Chemotherapy-induced emesis
Major Benefits of Fosaprineon 150mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Fosaprineon 150mg Injection:
- Headache
- Hiccup
- Indigestion
- Fatigue
- Decreased appetite
- Constipation
How to use Fosaprineon 150mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Fosaprineon 150mg Injection works:
Neupax 150mg injection combats nausea and vomiting. This antiemetic medication functions by inhibiting the activity of a neurotransmitter (neurokinin) within the brain, a substance that can trigger these side effects during cancer therapy (chemotherapy).
SAFETY ADVICE
AlcoholUNSAFE
Combining Fosaprineon 150mg Injection and alcohol is not advised due to safety concerns.
PregnancySAFE IF PRESCRIBED
The injectable formulation of fosaprineon (150mg) is typically deemed safe for use during gestation. Preclinical trials using animal models have revealed minimal or no harmful consequences for fetal development; nonetheless, data from human trials remain scarce.
Breast feedingCONSULT YOUR DOCTOR
The use of Fosaprineon 150mg Injection while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
The administration of Fosaprineon 150mg Injection can lead to reduced alertness, visual disturbances, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneySAFE IF PRESCRIBED
Fosaprineon 150mg injection poses no safety concerns for patients with renal impairment; dosage modification is unnecessary.
LiverCAUTION
Fosaprineon 150mg Injection requires careful administration in individuals with severe hepatic impairment. Dosage modification for Fosaprineon 150mg Injection might be necessary. Physician consultation is advised. Dosage alteration is not usually advised for patients exhibiting moderate to severe hepatic dysfunction.
What if you forget to take Fosaprineon 150mg Injection :
Should you forget a Fosaprineon 150mg Injection, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Fosaprineon 150mg Injection
| Label | Value |
|---|---|
| Chemical Category | Morpholine-based phenyl derivative |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Class | Substances Blocking NK1 Receptors |
